Jointown Pharmaceutical Group Co. Overview

  • Year Founded
  • 1985

Year Founded

  • Status
  • Public

  • Employees
  • 30,100

Employees

  • Stock Symbol
  • 600998

Stock Symbol

  • Investments
  • 21

  • Share Price
  • $0.69
  • (As of Monday Closing)

Jointown Pharmaceutical Group Co. General Information

Description

Jointown Pharmaceutical Group Co Ltd is engaged in the business of wholesaling drugs and medical devices. The company offers logistics and other value-added services and primarily serves medical institutions, wholesale enterprises, and retail pharmacies.

Contact Information

Website
www.jztey.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • No. 5 Longxing West Street
  • Wuhan, Hanyang 430051
  • China
Primary Industry
Distributors/Wholesale (B2C)
Other Industries
Medical Supplies
Stock Exchange
SHG
Corporate Office
  • No. 5 Longxing West Street
  • Wuhan, Hanyang 430051
  • China

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jointown Pharmaceutical Group Co. Stock Performance

As of 24-Mar-2025, Jointown Pharmaceutical Group Co.’s stock price is $0.69. Its current market cap is $3.49B with 5.04B shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.69 $0.70 $0.61 - $0.92 $3.49B 5.04B 27.2M $0.06

Jointown Pharmaceutical Group Co. Financials Summary

As of 30-Sep-2024, Jointown Pharmaceutical Group Co. has a trailing 12-month revenue of $20.8B.

In Thousands,
USD
TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 5,124,873 4,781,308 4,597,089 6,338,577
Revenue 20,786,120 21,221,540 20,851,341 18,957,088
EBITDA 556,325 687,034 683,595 778,235
Net Income 285,111 307,290 309,592 379,170
Total Assets 14,405,636 13,089,905 13,379,899 13,482,040
Total Debt 2,041,216 2,080,596 2,203,357 2,664,502
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Jointown Pharmaceutical Group Co. Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Jointown Pharmaceutical Group Co.‘s full profile, request access.

Request a free trial

Jointown Pharmaceutical Group Co. Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Jointown Pharmaceutical Group Co. Investments & Acquisitions (21)

Jointown Pharmaceutical Group Co.’s most recent deal was a Early Stage VC with WEMT Medical for . The deal was made on 25-Sep-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
WEMT Medical 25-Sep-2024 Early Stage VC Surgical Devices
Yuntai Network 07-Nov-2023 Later Stage VC Enterprise Systems (Healthcare)
Jiu Zhou Yi Yao Gong Ying Lian 23-Oct-2023 Joint Venture Information Services (B2C)
New Longitudinal 23-Sep-2022 Later Stage VC Diagnostic Equipment
AmCare Genomics 27-Apr-2022 Later Stage VC Laboratory Services (Healthcare)
You’re viewing 5 of 21 investments and acquisitions. Get the full list »

Jointown Pharmaceutical Group Co. ESG

Risk Overview

Risk Rating

Updated May, 31, 2024

25.5 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,946

Rank

Percentile

Food Retailers

Industry

of 188

Rank

Percentile

Drug Retail

Subindustry

of 32

Rank

Percentile

To view Jointown Pharmaceutical Group Co.’s complete esg history, request access »

Jointown Pharmaceutical Group Co. Exits (4)

Jointown Pharmaceutical Group Co.’s most recent exit was on 10-Jul-2019 from Zhongke Tongda. The exit was categorized as with 3 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Zhongke Tongda 10-Jul-2019 Completed
  • 3 buyers
Hongyuan Pharmaceutical Technology 16-Feb-2016 Completed
  • 7 buyers
Kaxingtianxia 07-Sep-2015 Completed
  • 6 buyers
Kaxingtianxia 06-May-2014 Early Stage VC Completed
  • 2 buyers
To view Jointown Pharmaceutical Group Co.’s complete exits history, request access »

Jointown Pharmaceutical Group Co. FAQs

  • When was Jointown Pharmaceutical Group Co. founded?

    Jointown Pharmaceutical Group Co. was founded in 1985.

  • Where is Jointown Pharmaceutical Group Co. headquartered?

    Jointown Pharmaceutical Group Co. is headquartered in Wuhan, China.

  • What is the size of Jointown Pharmaceutical Group Co.?

    Jointown Pharmaceutical Group Co. has 30,100 total employees.

  • What industry is Jointown Pharmaceutical Group Co. in?

    Jointown Pharmaceutical Group Co.’s primary industry is Distributors/Wholesale (B2C).

  • Is Jointown Pharmaceutical Group Co. a private or public company?

    Jointown Pharmaceutical Group Co. is a Public company.

  • What is Jointown Pharmaceutical Group Co.’s stock symbol?

    The ticker symbol for Jointown Pharmaceutical Group Co. is 600998.

  • What is the current stock price of Jointown Pharmaceutical Group Co.?

    As of 24-Mar-2025 the stock price of Jointown Pharmaceutical Group Co. is $0.69.

  • What is the current market cap of Jointown Pharmaceutical Group Co.?

    The current market capitalization of Jointown Pharmaceutical Group Co. is $3.49B.

  • What is Jointown Pharmaceutical Group Co.’s current revenue?

    The trailing twelve month revenue for Jointown Pharmaceutical Group Co. is $20.8B.

  • What is Jointown Pharmaceutical Group Co.’s annual earnings per share (EPS)?

    Jointown Pharmaceutical Group Co.’s EPS for 12 months was $0.06.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »